Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,002,178 papers from all fields of science
Search
Sign In
Create Free Account
VePesid-Ifosfamide-Platinol Regimen
Known as:
VP16-Ifosfamide-Platinol Regimen
, Etoposide-Ifosfamide-Cisplatin Regimen
, VIP
Expand
A regimen consisting of etoposide, ifosfamide and cisplatin used for the treatment of advanced-stage germ cell gonadal cancers.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Cisplatin
Etoposide
Ifosfamide
Testicular malignant germ cell tumor
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95
A. Simon
,
M. Péoch
,
+17 authors
R. Gressin
British Journal of Haematology
2010
Corpus ID: 22880672
Peripheral T‐Cell lymphomas (PTCL) are relatively rare diseases but appear to be highly aggressive and display worse remission…
Expand
Highly Cited
2008
Highly Cited
2008
A randomized trial comparing compression, perclose proglide™ and Angio‐Seal VIP™ for arterial closure following percutaneous coronary intervention: The cap trial
Jack L. Martin
,
Antonis Pratsos
,
+5 authors
T. Shapiro
Catheterization and cardiovascular interventions
2008
Corpus ID: 24153113
Objective: This prospective randomized trial compared the Angio‐Seal VIP™ with Perclose Proglide™ and to manual compression with…
Expand
Highly Cited
2003
Highly Cited
2003
Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors
Stuart Hinton
,
P. Catalano
,
+5 authors
P. Loehrer
Cancer
2003
Corpus ID: 7818512
Various staging systems have been proposed for disseminated germ cell neoplasms. The Indiana University staging system was based…
Expand
Highly Cited
2003
Highly Cited
2003
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an…
H. Schmoll
,
C. Kollmannsberger
,
+11 authors
C. Bokemeyer
Journal of Clinical Oncology
2003
Corpus ID: 10320603
PURPOSE Patients with disseminated germ cell cancer and poor prognosis (International Germ Cell Cancer Collaborative Group…
Expand
Highly Cited
2001
Highly Cited
2001
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma
P. Loehrer
,
M. Jiroutek
,
+5 authors
David H. Johnson
Cancer
2001
Corpus ID: 25381601
Patients with thymic tumors (thymoma and thymic carcinoma) are known to respond to a variety of chemotherapeutic agents…
Expand
Highly Cited
1999
Highly Cited
1999
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.
C. Bokemeyer
,
C. Kollmannsberger
,
+8 authors
C. Nichols
Journal of Clinical Oncology
1999
Corpus ID: 29576063
PURPOSE To compare first-line high-dose chemotherapy (HD-CT) with autologous blood stem-cell transplantation to standard-dose…
Expand
Highly Cited
1998
Highly Cited
1998
Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology…
Craig R. Nichols
,
P. Catalano
,
E. Crawford
,
N. Vogelzang
,
L. Einhorn
,
P. Loehrer
Journal of Clinical Oncology
1998
Corpus ID: 39778263
PURPOSE To compare standard therapy with bleomycin, etoposide, and cisplatin (BEP) to experimental therapy with etoposide…
Expand
Highly Cited
1997
Highly Cited
1997
High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
R. Motzer
,
M. Mazumdar
,
D. Bajorin
,
G. Bosl
,
P. Lyn
,
V. Vlamis
Journal of Clinical Oncology
1997
Corpus ID: 23812174
PURPOSE A treatment program that included high-dose carboplatin, etoposide, and cyclophosphamide (CEC) followed by autologous…
Expand
Highly Cited
1993
Highly Cited
1993
Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte‐colony stimulating factor accelerate both neutrophil and platelet recovery after high‐dose VP16, ifosfamide and cisplatin
W. Brugger
,
Rainer Birken
,
+6 authors
L. Kanz
British Journal of Haematology
1993
Corpus ID: 28931461
Summary. We report on the chemotherapy plus granulocyte colony‐stimulating factor (G‐CSF) induced mobilization of peripheral…
Expand
Highly Cited
1988
Highly Cited
1988
Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.
P. Loehrer
,
R. Lauer
,
B. Roth
,
S. Williams
,
L. A. Kalasinski
,
L. Einhorn
Annals of Internal Medicine
1988
Corpus ID: 9126334
STUDY OBJECTIVE To determine the efficacy of the addition of ifosfamide to cisplatin plus etoposide (VIP), or vinblastine (VeIP…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE